Skip to main content

Table 3 Individual characteristics at enrollment and their association with death (n = 95)

From: Mortality & recurrent seizure risk after new-onset seizure in HIV-positive Zambian adults

Characteristic Hazard Ratio [95% CI] P-value a
Gender, female 0.9 [0.5–1.7] 0.745
Age, mean 1.01 [0.98–1.05] 0.383
WHO HIV clinical stage III or IVb 19.1 [1.1–333.4] 0.01
cART use at enrollment 1.5 [0.8–2.9] 0.240
Karnofsky score < 50 at enrollment 1.8 [0.9–3.8] 0.125
Seizure severity at enrollment
 Brief, Single Referent 0.173
 Multiple, prolonged 1.7 [0.7–3.9]  
 Status epilepticus 2.6 [0.96–7.3]  
CNS opportunistic infection 0.9 [0.4–2.2] 0.889
Unknown etiology 2.2 [1.1–4.4] 0.025
Among those with CSF (n = 61) 2.1 [0.8–5.3] 0.129
  1. Data is presented as the hazards ratio for the listed characteristic versus the null with a hazards ratio of 1.0 indicating no difference. CI confidence interval, WHO World Health Organization, cART combination antiretroviral therapy, CNS central nervous system, CSF cerebrospinal fluid
  2. aLog-Rank Tests bAs compared to WHO clinical stage I or II